NCI Rising Scholars: Cancer Research Seminar Series (Registration)

Submitted by nusratyj on Tue, 12/06/2022 - 16:23

Registration

OMB No.: 0925-0740
Expiration Date: 9/30/2025

Public reporting burden for this collection of information is estimated to average 3 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0740). Do not return the completed form to this address.

Your Information
Title
Suffix
Address
Title/Position/Career Stage
Additional Registration Questions

 

Indicate which seminars you would like to attend:

"Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation"
Dr. Chris Gibson
"Psychosocial determinants of colorectal Cancer screening uptake among African-American men: understanding the role of masculine role norms, medical mistrust, and normative support"
Dr. Charles R. Rogers
"Qualitative analysis of shared decision-making for chemoprevention in the primary care setting: provider-related barriers"
Dr. Tarsha Jones
"Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data"
Dr. Randi Williams
"Direct epitranscriptomic regulation of mammalian translation initiation through N4-acetylcytidine"
Dr. Daniel Arango
"Enduring Cancer Disparities by Persistent Poverty, Rurality, and Race: 1990-1992 to 2014-2018"
Dr. Jennifer Moss
"Are beliefs about the importance of genetics for cancer prevention and early detection associated with high risk cancer genetic testing in the U.S. Population?"
Dr. Sukh Makhnoon
“Immune cell gene expression signatures in diffuse glioma are associated with IDH mutation status, patient outcome and malignant cell state, and highlight the importance of specific cell subsets in glioma biology”
Dr. Bharati Mehani
“Distinct MUNC lncRNA structural domains regulate transcription of different promyogenic factors"
Dr. Roza Przanowska
“Chondroitin Sulfate Proteoglycans Are De Facto Cellular Receptors for Human Papillomavirus 16 under High Serum Conditions"
Dr. Nathan Fons
"Altered propionate metabolism contributes to tumour progression and aggressiveness"
Dr. Ana Gomes
Request for Reasonable Accommodations